Are you looking to evaluate enterprise technologies faster? Sign up to watch GigaOm's 4-part on-demand research video series that breakdowns our research methodology and what differentiates us as a leader in emerging technology research.

Watch the Videos
bigstock–199147276

AI-Driven Drug Safety v 1.0

How AI Automates Drug Safety Reporting to Government Health Agencies: A Product Manager’s Approach to Innovation

Summary

Tracking and reporting adverse drug reactions is serious business for pharmaceutical companies, requiring them to process large and diverse streams of data from multiple sources to detect incidents. Strict reporting requirements and timelines from the FDA and other mandates impose sharp fiscal penalties for delayed response. This GigaOm Business and Technology Impact report describes how one company applied automation and AI to enhance detection, reduce response times, and improve patient outcomes.

Full report available to GigaOm Subscribers.

Subscribe to GigaOm Research